Botulism: life-threatening illness
pdf

Keywords

C. botulinum,
botulism,
botulinum neurotoxin.

How to Cite

ABO ARKIA, A. R. (2021) “Botulism: life-threatening illness”, One Health & Risk Management , 2(4S), p. 97. Available at: https://journal.ohrm.bba.md/index.php/journal-ohrm-bba-md/article/view/270 (Accessed: 8July2025).

Abstract

Introduction. Botulism is a potentially fatal syndrome of diffuse, flaccid paralysis caused by botulinum neurotoxin (BoNT), produced by the bacterium Clostridium botulinum. The toxin is produced as the bacteria multiply; the bacteria multiply under anaerobic and mildly acidic conditions. The neurotoxin BoNT is considered the deadliest toxin known due to its high potency and lethality. Based on the different serotypes known today, a classification of serotype variants termed subtypes has been proposed according to sequence diversity and immunological properties. Authors described seven types of botulinum toxins (A–G), but human botulism is primarily caused by types A, B, E, while types C, D and E cause illness in other mammals, birds and fish. Most studies demonstrated that antitoxin should be administered as soon as possible after a clinical diagnosis. There is no vaccination to protect people against botulism. The effective prevention measures of foodborne botulism are based on good practice of food products preparation and compliance with basic hygiene rules.

Material and methods. The purpose of the study was to find relevant publications on the etiology, epidemiology, diagnostic methods and prevention measures of botulism, critically analyze them and describe the research findings. Therefore, a bibliographic review was performed using online databases as PubMed, Scopus, Web of Science, and Google Scholar as well as the following keywords C. botulinum, botulism, botulinum neurotoxin for identifying the evidence published both in the country and abroad.

Results. When analyzing the existing evidence, there was noticed that botulism is a severe neurological disease caused by the complex family of botulinum neurotoxins that can be acquired through exposure to the pre-formed toxin via improperly-stored food, iatrogenic injection, and bioterrorism. Moreover, in infants and wound botulism cases it can be the result of a systemic release of the toxin in vivo. Most studies have shown that botulism is an intoxication usually caused by ingestion of potent neurotoxins, the botulinum toxins, formed in contaminated foods. Person to person transmission of botulism does not occur.

The standard method for rapid diagnosis is positive laboratory findings (detection of toxin in the patient's serum, feces, gastric, intestinal contents, wound swabs and tissues), however the clinical manifestations and patient history are also very important. Laboratory rapid diagnosis of botulism is required for successful therapy, considering that it is a life-threatening condition. This disease can be fatal if left untreated, but most people who receive a prompt diagnosis and treatment can fully recover from the illness.

Conclusions. The results of many scientific papers have demonstrated that botulism is a rare but serious condition caused by toxins from bacteria called Clostridium botulinum. The authors described the principle of diagnosis and showed that it is usually based on anamnesis and clinical findings followed by laboratory investigations: the presence of BoNT in serum, stool or food, or a culture of C. botulinum. Also, each case of botulism is considered a public health emergency and requires immediate report of the suspected case to the ministry of health or national agency of public health.

pdf

|Views: 154| |pdf Downloads: 48|


pdf
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Downloads

Download data is not yet available.

ANNOUNCEMENT

Starting from July 1, 2025, the article processing fee will be 20 EUR (or the equivalent in MDL at the official exchange rate of the National Bank of Moldova). The publication fee for an accepted article will be 150 EUR (or the equivalent in MDL).

Details here:

Processing Fee
A processing fee of 20 EUR (or the equivalent in MDL) will be charged for articles accepted for scientific review by the editorial committee of the One Health and Risk Management journal.
Note: This fee will only be charged if your article has been technically reviewed and accepted.

Publication Fee
Starting from 01.07.2025, a fee of 150 EUR (or the equivalent in MDL) will be charged for articles accepted for publication.
Additionally, authors will bear the cost of English language editing/translation services if the manuscript requires intervention. The fee is 5 EUR (or the equivalent in MDL) per page edited/translated.
The total cost for English editing/translation services will be communicated by the Editorial Board after the manuscript is accepted for publication.

Payment Details:
Payments should be made in MDL to the bank account opened in the name of the Biosafety and Biosecurity Association of the Republic of Moldova.
The invoice will be issued by the end of the month in which the payment was made.

Organization: Biosafety and Biosecurity Association of the Republic of Moldova
Address: 5C A. Cozmescu Street
Fiscal Code: 1017620004120
Bank Code (SWIFT): AGRNMD2X451
IBAN: MD34AG000000022513622370